We are live on ! Find out more
NFA

Nationwide Fund Advisors Portfolio holdings

AUM $2.42B
1-Year Est. Return 17.68%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+82.68%
AUM
$23B
AUM Growth
-$294M
Cap. Flow
-$302M
Cap. Flow %
-1.31%
Top 10 Hldgs %
10.05%
Holding
3,336
New
91
Increased
1,121
Reduced
1,460
Closed
84

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$34.1M
2
CMCSA icon
Comcast
CMCSA
+$34.1M
3
XRAY icon
Dentsply Sirona
XRAY
+$34.1M
4
BAX icon
Baxter International
BAX
+$31.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$27.7M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$42.9M
2
CTSH icon
Cognizant
CTSH
+$38.1M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$34.6M
4
WEC icon
WEC Energy
WEC
+$34.5M
5
AMZN icon
Amazon
AMZN
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.62%
3 Financials 13.32%
4 Industrials 11.99%
5 Consumer Discretionary 10.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
2851
Ocular Therapeutix
OCUL
$1.89B
$93K ﹤0.01%
9,608
CUTR
2852
DELISTED
Cutera, Inc.
CUTR
$93K ﹤0.01%
8,311
-952
-10% -$10.8K
STML
2853
DELISTED
Stemline Therapeutics, Inc.
STML
$93K ﹤0.01%
13,725
+3,540
+35% +$17.3K
ANTH
2854
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$93K ﹤0.01%
3,227
RYZ
2855
Ryerson Holding Corp
RYZ
$1.4B
$92K ﹤0.01%
16,614
+8,996
+118% +$35K
ATRS
2856
DELISTED
Antares Pharma, Inc.
ATRS
$92K ﹤0.01%
105,808
+5,626
+6% +$5.44K
ADUS icon
2857
Addus HomeCare
ADUS
$2.12B
$91K ﹤0.01%
5,322
ALCO icon
2858
Alico
ALCO
$283M
$91K ﹤0.01%
3,280
COLL icon
2859
Collegium Pharmaceutical
COLL
$1.16B
$91K ﹤0.01%
5,000
+731
+17% +$13.3K
CRDF icon
2860
Cardiff Oncology
CRDF
$72.3M
$91K ﹤0.01%
272
HBIO icon
2861
Harvard Bioscience
HBIO
$28.5M
$91K ﹤0.01%
3,018
KOPN icon
2862
Kopin
KOPN
$769M
$91K ﹤0.01%
54,668
+11,834
+28% +$22.6K
NDLS icon
2863
Noodles & Co
NDLS
$106M
$91K ﹤0.01%
954
+76
+9% +$7.35K
PAMT
2864
PAMT Corp
PAMT
$368M
$91K ﹤0.01%
11,848
LRMR icon
2865
Larimar Therapeutics
LRMR
$427M
$90K ﹤0.01%
1,120
XONE
2866
DELISTED
The ExOne Company
XONE
$90K ﹤0.01%
6,816
HMTV
2867
DELISTED
Hemisphere Media Group, Inc.
HMTV
$89K ﹤0.01%
6,805
NVEE
2868
DELISTED
NV5 Global
NVEE
$88K ﹤0.01%
13,116
CMT icon
2869
Core Molding Technologies
CMT
$210M
$86K ﹤0.01%
6,868
LYG icon
2870
Lloyds Banking Group
LYG
$90.3B
$86K ﹤0.01%
21,662
-129,644
-86% -$502K
ULH icon
2871
Universal Logistics Holdings
ULH
$513M
$86K ﹤0.01%
5,203
-5,100
-50% -$75.1K
VSTM icon
2872
Verastem
VSTM
$511M
$86K ﹤0.01%
4,551
+2,817
+162% +$45.2K
CDMO
2873
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$86K ﹤0.01%
29,188
+11,007
+61% +$58.9K
REXI
2874
DELISTED
RESOURCE AMERICA INC CL-A
REXI
$86K ﹤0.01%
14,824
PMTS icon
2875
CPI Card Group
PMTS
$263M
$85K ﹤0.01%
2,063
+100
+5% +$4.17K

Similar funds

Nationwide Fund Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Nationwide Fund Advisors held 3,336 positions worth $23B, down 1.3% from $23.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Nationwide Fund Advisors's Q1 2016 filing shows 91 new, 1,121 increased, 1,460 reduced and 84 closed positions. Its largest new stake was iShares Russell 1000 Growth ETF: 400,000 shares worth $9.98M. The largest sale was Mastercard, an estimated $42.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Nationwide Fund Advisors's largest Q1 2016 buy was iShares Russell 1000 Growth ETF: 400,000 shares worth $9.98M.
  • Nationwide Fund Advisors added most to AbbVie in Q1 2016, an estimated $34.1M increase.
  • Nationwide Fund Advisors's biggest Q1 2016 reduction was Mastercard, cutting an estimated $42.9M.
  • Nationwide Fund Advisors fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $34.6M.
  • Nationwide Fund Advisors's ten largest holdings make up 10% of its $23B portfolio in Q1 2016.
  • Nationwide Fund Advisors opened 91 new positions and closed 84 in Q1 2016.
  • Nationwide Fund Advisors's portfolio value fell 1.3% quarter-over-quarter to $23B.

Based on Nationwide Fund Advisors's 13F filing for Q1 2016, filed 5 May 2016.